GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (NAS:VBIV) » Definitions » E10

VBI Vaccines (VBI Vaccines) E10 : $-72.80 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is VBI Vaccines E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

VBI Vaccines's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.007. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-72.80 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 12.60% per year. During the past 5 years, the average E10 Growth Rate was 12.00% per year. During the past 10 years, the average E10 Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of VBI Vaccines was 15.20% per year. The lowest was -64.10% per year. And the median was -4.95% per year.

As of today (2024-04-29), VBI Vaccines's current stock price is $0.560001. VBI Vaccines's E10 for the quarter that ended in Dec. 2023 was $-72.80. VBI Vaccines's Shiller PE Ratio of today is .


VBI Vaccines E10 Historical Data

The historical data trend for VBI Vaccines's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VBI Vaccines E10 Chart

VBI Vaccines Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -119.37 -109.09 -75.96 -72.68 -72.80

VBI Vaccines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.68 -74.34 -75.30 -74.54 -72.80

Competitive Comparison of VBI Vaccines's E10

For the Biotechnology subindustry, VBI Vaccines's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VBI Vaccines's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VBI Vaccines's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where VBI Vaccines's Shiller PE Ratio falls into.



VBI Vaccines E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, VBI Vaccines's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.007/129.4194*129.4194
=-0.007

Current CPI (Dec. 2023) = 129.4194.

VBI Vaccines Quarterly Data

per share eps CPI Adj_EPS
201403 -21.298 99.695 -27.648
201406 -11.248 100.560 -14.476
201409 -4.891 100.428 -6.303
201412 -10.337 99.070 -13.504
201503 -348.469 99.621 -452.702
201506 -9.667 100.684 -12.426
201509 -12.000 100.392 -15.470
201512 -25.876 99.792 -33.558
201603 -1.800 100.470 -2.319
201606 -6.900 101.688 -8.782
201609 -6.000 101.861 -7.623
201612 -6.900 101.863 -8.767
201703 -6.600 102.862 -8.304
201706 -6.600 103.349 -8.265
201709 -7.200 104.136 -8.948
201712 -6.000 104.011 -7.466
201803 -5.700 105.290 -7.006
201806 -7.800 106.317 -9.495
201809 -7.200 106.507 -8.749
201812 -8.400 105.998 -10.256
201903 -4.500 107.251 -5.430
201906 -3.900 108.070 -4.670
201909 -4.500 108.329 -5.376
201912 -0.600 108.420 -0.716
202003 -1.500 108.902 -1.783
202006 -1.200 108.767 -1.428
202009 -1.800 109.815 -2.121
202012 -1.800 109.897 -2.120
202103 -2.100 111.754 -2.432
202106 -2.100 114.631 -2.371
202109 -1.800 115.734 -2.013
202112 -2.100 117.630 -2.310
202203 -2.468 121.301 -2.633
202206 -5.310 125.017 -5.497
202209 -2.930 125.227 -3.028
202212 -2.450 125.222 -2.532
202303 -3.217 127.348 -3.269
202306 -5.180 128.729 -5.208
202309 -1.010 129.860 -1.007
202312 -0.007 129.419 -0.007

Add all the adjusted EPS together and divide 10 will get our e10.


VBI Vaccines  (NAS:VBIV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


VBI Vaccines E10 Related Terms

Thank you for viewing the detailed overview of VBI Vaccines's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


VBI Vaccines (VBI Vaccines) Business Description

Traded in Other Exchanges
Address
160 Second Street, Floor 3, Cambridge, MA, USA, 02142
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Executives
Steven Gillis director 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Vaughn B Himes director C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
John Robert Dillman officer: Chief Commercial Officer C/O VBI VACCINES INC., 160 SECOND STREET, FLOOR 3, CAMBRIDGE MA 02142
Nell Beattie officer: Director, Corp Development/IR 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Linda Bain director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Damian Braga director 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Francisco Diaz-mitoma officer: Chief Medical Officer 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Christopher Mcnulty officer: CFO and Head of BD C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Jeff Baxter director, officer: President and CEO C/O VBI VACCINES INC.,, 222 THIRD STREET, STE 2241, CAMBRIDGE MA 02142
Joanne Cordeiro director 171 SWANTON STREET, UNIT 48, WINCHESTER MA 01890
Blaine H. Mckee director C/O HART, 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746
Tomer Kariv director C/O ARNO THERAPEUTICS, INC., 200 ROUTE 31 NORTH, SUITE 104, FLEMINGTON NJ 08822
Joseph Edelman 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003